Total marketcap
Total volume
BTC 48.84%     ETH 17.27%

AstraZeneca AZN Stock

64.13 USD {{ price }} 0.038989% {{change_pct}}%
Market Cap
198.83B USD
LOW - HIGH [24H]
63.26 - 64.58 USD
8.09M USD
{{ volume }}
P/E Ratio
Earnings per share
1.9 USD

AstraZeneca Price Chart

AstraZeneca AZN Financial and Trading Overview

AstraZeneca stock price 64.13 USD
Previous Close 72.77 USD
Open 74 USD
Bid 0 USD x 1000
Ask 0 USD x 900
Day's Range 73.59 - 74.74 USD
52 Week Range 52.65 - 76.56 USD
Volume 4.45M USD
Avg. Volume 4.14M USD
Market Cap 231.3B USD
Beta (5Y Monthly) 0.194636
PE Ratio (TTM) 48.141937
Forward Dividend & Yield 1.45 (1.99%)
Ex-Dividend Date February 23, 2023
1y Target Est 80.25 USD

AZN Valuation Measures

Enterprise Value 1.42T USD
Trailing P/E 48.141937
Forward P/E 17.47541
PEG Ratio (5 yr expected) 1.52
Price/Sales (ttm) 5.276063
Price/Book (mrq) 38.910892
Enterprise Value/Revenue 32.359
Enterprise Value/EBITDA 95.3

Trading Information

AstraZeneca Stock Price History

Beta (5Y Monthly) 0.194636
52-Week Change 22.14%
S&P500 52-Week Change 20.43%
52 Week High 76.56 USD
52 Week Low 52.65 USD
50-Day Moving Average 73.91 USD
200-Day Moving Average 66.48 USD

AZN Share Statistics

Avg. Volume (3 month) 4.14M USD
Avg. Daily Volume (10-Days) 5.04M USD
Shares Outstanding 3.1B
Float 18.59B
Short Ratio 1.42
% Held by Insiders 0.0060%
% Held by Institutions 18.10%
Shares Short 4.88M
Short % of Float N/A
Short % of Shares Outstanding 0.16%

Dividends & Splits

Trailing Annual Dividend Rate 2.9
Trailing Annual Dividend Yield 3.98%
5 Year Average Dividend Yield 277.00%
Payout Ratio 0.96029997
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023


Profit Margin 10.73%
Operating Margin (ttm) 23.09%
Gross Margin 84.30%
EBITDA Margin 33.95%

Management Effectiveness

Return on Assets (ttm) 6.42%
Return on Equity (ttm) 13.05%

Income Statement

Revenue (ttm) 43.84B USD
Revenue Per Share (ttm) 2.35 USD
Quarterly Revenue Growth (yoy) -4.50%
Gross Profit (ttm) 35.73B USD
Net Income Avi to Common (ttm) 4.7B USD
Diluted EPS (ttm) 1.55
Quarterly Earnings Growth (yoy) 367.09%

Balance Sheet

Total Cash (mrq) 6.46B USD
Total Cash Per Share (mrq) 0.35 USD
Total Debt (mrq) 32.47B USD
Total Debt/Equity (mrq) 90.68 USD
Current Ratio (mrq) 0.896
Book Value Per Share (mrq) 1.917715

Cash Flow Statement

Operating Cash Flow (ttm) 9.71B USD
Levered Free Cash Flow (ttm) 9.69B USD

Profile of AstraZeneca

Country United States
State N/A
City Cambridge
Address 1 Francis Crick Avenue
Phone 44 20 3749 5000
Website https://www.astrazeneca.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 83500

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Q&A For AstraZeneca Stock

What is a current AZN stock price?

AstraZeneca AZN stock price today per share is 64.13 USD.

How to purchase AstraZeneca stock?

You can buy AZN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for AstraZeneca?

The stock symbol or ticker of AstraZeneca is AZN.

Which industry does the AstraZeneca company belong to?

The AstraZeneca industry is Drug Manufacturers-General.

How many shares does AstraZeneca have in circulation?

The max supply of AstraZeneca shares is 3.1B.

What is AstraZeneca Price to Earnings Ratio (PE Ratio)?

AstraZeneca PE Ratio is 33.75263200 now.

What was AstraZeneca earnings per share over the trailing 12 months (TTM)?

AstraZeneca EPS is 1.9 USD over the trailing 12 months.

Which sector does the AstraZeneca company belong to?

The AstraZeneca sector is Healthcare.

AstraZeneca AZN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16041.62 USD
5.07B USD 15869.24 USD 16061.82 USD 5.07B USD
US100 NDX 18004.7 USD
1.04B USD 17808.3 USD 18034.8 USD 1.04B USD
Nasdaq Nordea SmartBeta Momentu NQNDMOT 1020.51 SEK 99.58 USD
NASDAQ 100 Ex Tech Sector NDXX 5312.53 USD
5259.97 USD 5321.11 USD
Nasdaq-100 ESG JPY Index NDXESG07 1815.23 JPY 12.56 USD
1794.59 JPY 12.42 USD 1818.37 JPY 12.58 USD
Stlmt ID NASDAQ 100 XQO 16266.86 USD
15738.2 USD 16639.8 USD
NASDAQ 100 Notional Net Total R XNDXNNR 20717.8 USD
20491.8 USD 20752.4 USD
NASDAQ Biotechnology NBI 4455.98 USD
4395.93 USD 4478.28 USD
NASDAQ 100 After Hours Indicato QIV 17974.06 USD
17942.83 USD 17987.43 USD
NASDAQ HealthCare IXHC 999.85 USD
988.99 USD 1003.07 USD
OMX GES Sustainability Nordic C OMXSUSTNCCAPPI 1191.64 SEK 116.27 USD
Folksam OMXS60 FMOMXS60 167.08 SEK 16.3 USD